Cubist Systematic Strategies’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,500
Closed -$704K 2914
2025
Q1
$704K Sell
6,500
-13,992
-68% -$1.22M ﹤0.01% 2003
2024
Q4
$973K Buy
20,492
+2,744
+15% +$166K 0.01% 1814
2024
Q3
$1.74M Buy
17,748
+5,896
+50% +$761K 0.01% 1506
2024
Q2
$1.94M Buy
11,852
+648
+6% +$92.3K 0.01% 1355
2024
Q1
$1.71M Buy
11,204
+7,360
+191% +$1.22M 0.01% 1769
2023
Q4
$1.21M Buy
3,844
+2,876
+297% +$1.04M 0.01% 1906
2023
Q3
$430K Buy
+968
New +$437K ﹤0.01% 2401

Other funds holding AGL

Cubist Systematic Strategies's AGL Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 30,037 shares — an estimated $1.73M sold.

Cubist Systematic Strategies first reported a position in AGL in Q2 2021 and held it in 12 quarters. The position peaked at $13.4M in Q3 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 30,037 Agilon Health shares in Q3 2025, an estimated $1.73M.
  • Cubist Systematic Strategies first reported a position in Agilon Health in Q2 2021 and held it in 12 quarters.
  • Cubist Systematic Strategies's Agilon Health position peaked at $13.4M in Q3 2022.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.